By uniting a cross-disciplinary hub of people and teams in a collaborative, not-for-profit model, the PROOF Centre can speed up development of new blood tests to improve patient management and to expedite drug development.
The PROOF Centre has biomarker programs to develop simple blood tests to better predict, diagnose, manage and treat disease, by harnessing the power of clinical, molecular and computational science. We have biomarker programs across a multitude of disease indications.
The PROOF Centre’s service arm provides expertise in computation, “-omic” science and biomarker workflow to organizations seeking to discover, develop and implement blood-based molecular biomarkers in a clinical setting.
2018 Alotaibi NM, Chen V, Hollander Z, Hague CJ, Murphy DT, Leipsic JA, DeMarco ML, FitzGerald JM, McManus BM, Ng RT, Sin DD. Phenotyping COPD exacerbations using imaging and blood-based biomarkers. International Journal of Chronic Obstructive Pulmonary Disease. 2018 January 8. DOI: 10.2147/COPD.S152484...Read more